Cargando…

Diet and Physical Activity in Adult Dominant Polycystic Kidney Disease: A Review of the Literature

Autosomal polycystic kidney disease is the most common inherited kidney disease determining 5% of all end-stage kidney disease. The only therapy approved for this condition is Tolvaptan, which, with its aquaretic effect, has a strong effect on patients’ daily life. Recently, the literature has been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Capelli, Irene, Lerario, Sarah, Aiello, Valeria, Provenzano, Michele, Di Costanzo, Roberta, Squadrani, Andrea, Vella, Anna, Vicennati, Valentina, Poli, Carolina, La Manna, Gaetano, Baraldi, Olga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10255338/ https://www.ncbi.nlm.nih.gov/pubmed/37299584 http://dx.doi.org/10.3390/nu15112621

Ejemplares similares

Impact of Baseline Clinical Variables on SGLT2i’s Antiproteinuric Effect in Diabetic Kidney Disease
por: Capelli, Irene, et al.
Publicado: (2023)

Identification of expanded T-cell clones by spectratyping in nonfunctioning kidney transplants
por: Cappuccilli, Maria, et al.
Publicado: (2017)

Kidney transplantation in systemic sclerosis: Advances in graft, disease, and patient outcome
por: Maritati, Federica, et al.
Publicado: (2022)

Donor/Recipient Delta Age: A Possible Risk for Arterial Stenosis in Renal Transplantation
por: Pallotti, Giovanni, et al.
Publicado: (2015)

Gene Panel Analysis in a Large Cohort of Patients With Autosomal Dominant Polycystic Kidney Disease Allows the Identification of 80 Potentially Causative Novel Variants and the Characterization of a Complex Genetic Architecture in a Subset of Families
por: Mantovani, Vilma, et al.
Publicado: (2020)

Cabozantinib‐induced renal thrombotic microangiopathy
por: La Manna, Gaetano, et al.
Publicado: (2017)

Safety and Efficacy of Vedolizumab in Kidney Transplant Recipients With Crohn’s Disease
por: Busutti, Marco, et al.
Publicado: (2023)

Modifiers of Autosomal Dominant Polycystic Kidney Disease Severity: The Role of PKD1 Hypomorphic Alleles
por: Ambrosini, Enrico, et al.
Publicado: (2023)

Kidney Transplant in Fabry Disease: A Revision of the Literature
por: Capelli, Irene, et al.
Publicado: (2020)

Iloprost in Acute Post-kidney Transplant Atheroembolism: A Case Report of Two Successful Treatments
por: Corradetti, Valeria, et al.
Publicado: (2020)

An in vitro model of renal inflammation after ischemic oxidative stress injury: nephroprotective effects of a hyaluronan ester with butyric acid on mesangial cells
por: Baraldi, Olga, et al.
Publicado: (2017)

Removal of free light chains in hemodialysis patients without multiple myeloma: a crossover comparison of three different dialyzers
por: Donati, Gabriele, et al.
Publicado: (2016)

Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022)

Generalized aneurysmal disease in association with autosomal dominant polycystic disease
por: Ruderman, Irene, et al.
Publicado: (2014)

Nephrotic syndrome and autosomal dominant polycystic kidney disease
por: Visciano, Bianca, et al.
Publicado: (2012)

An Unusual Cardiac Manifestation in Autosomal Dominant Polycystic Kidney Disease
por: Catapano, Fausta, et al.
Publicado: (2012)

Fifteen-Year Analysis of Deceased Kidney Donation: A Single Transplant Center Experience in a Region of Northern Italy
por: Cuna, Vania, et al.
Publicado: (2017)

Autosomal dominant polycystic kidney disease in young adults
por: Martínez, Víctor, et al.
Publicado: (2022)

Precision Nephrology in Patients with Diabetes and Chronic Kidney Disease
por: Provenzano, Michele, et al.
Publicado: (2022)

Autosomal dominant polycystic kidney disease in Colombia
por: Camargo, Jessica T., et al.
Publicado: (2023)

Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease
por: Lai, Silvia, et al.
Publicado: (2016)

Kidney organoids generated from erythroid progenitors cells of patients with autosomal dominant polycystic kidney disease
por: Facioli, Roberta, et al.
Publicado: (2021)

Developments in the management of autosomal dominant polycystic kidney disease
por: Masoumi, Amirali, et al.
Publicado: (2008)

Hypertension in autosomal-dominant polycystic kidney disease (ADPKD)
por: Sans-Atxer, Laia, et al.
Publicado: (2013)

Umbilical hernia in autosomal dominant polycystic kidney disease
por: Hattori, Yoshinari, et al.
Publicado: (2014)

Diagnostic Imaging of Autosomal Dominant Polycystic Kidney Disease
por: Gradzik, Monika, et al.
Publicado: (2016)

Obturator hernia in autosomal dominant polycystic kidney disease
por: Jung, Jong Hwan, et al.
Publicado: (2018)

Autosomal dominant polycystic kidney disease: updated perspectives
por: Rastogi, Anjay, et al.
Publicado: (2019)

Educational Case: Autosomal Dominant Polycystic Kidney Disease
por: Frazier, Ryan L., et al.
Publicado: (2020)

Cerebral Microbleeds in Autosomal Dominant Polycystic Kidney Disease
por: Tsai, Li-Kai, et al.
Publicado: (2020)

Clinical burden of autosomal dominant polycystic kidney disease
por: Hung, Peir-Haur, et al.
Publicado: (2020)

Drug management of autosomal dominant polycystic kidney disease
por: Theivendran, Thiveya, et al.
Publicado: (2022)

Autosomal Dominant Polycystic Kidney Disease with Emphysematous Polycystic Renal Infection That Required Surgical Treatment
por: Watanabe, Kentaro, et al.
Publicado: (2018)

Factors Associated With the Development and Severity of Polycystic Liver in Patients With Autosomal Dominant Polycystic Kidney Disease
por: Kim, Yaerim, et al.
Publicado: (2023)

Everolimus-associated alveolar hemorrage relapse after drug discontinuation in a kidney transplant recipient
por: Busutti, Marco, et al.
Publicado: (2022)

Neutrophil Gelatinase‐Associated Lipocalin as a Biomarker of Allograft Function After Renal Transplantation: Evaluation of the Current Status and Future Insights
por: Cappuccilli, Maria, et al.
Publicado: (2017)

The Longitudinal Study of Liver Cysts in Patients With Autosomal Dominant Polycystic Kidney Disease and Polycystic Liver Disease
por: Matsuura, Ryo, et al.
Publicado: (2016)

Rituximab as First-Line Therapy in Severe Lupus Erythematosus with Neuropsychiatric and Renal Involvement: A Case-Report and Review of the Literature
por: Angeletti, Andrea, et al.
Publicado: (2017)

Pulmonary Embolism in a Patient With ADPKD Treated With Tolvaptan: From the Clinical Experience to the Analysis of the Food and Drug Administration Adverse Event Reporting System Registry
por: Aiello, Valeria, et al.
Publicado: (2021)

Renal disease progression in autosomal dominant polycystic kidney disease
por: Higashihara, Eiji, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_9j8fn7akngta7276c99kioerbm